CSIMarket
 


Molecular Templates Inc   (MTEM)
Other Ticker:  
 


Molecular Templates Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Molecular Templates Inc 's ROA in the fourth quarter of 2023?
Molecular Templates Inc achieved a return on average assets (ROA) of 11.89 % in its fourth quarter of 2023, which is below Molecular Templates Inc 's average return on assets, which stands at 30.13%.

ROA decreased relative to the period ending Sep 30 2023, due to the decline in net income.

However, within the Healthcare sector 51 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 26 to 404.

What is ROA?


Return On Assets (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Total Assets Change -63.73 % -62.83 % -74.79 % -51.89 % -49.29 %
Y / Y Net Income Change - -80.78 % 115.26 % -18.92 % 56.53 %
Net Income (TTM) in million 6 75 93 81 87
Return On Assets (TTM) 11.89 % 117.77 % 112.35 % 74.32 % 66.64 %
MTEM's Total Ranking # 404 # 26 # 29 # 32 # 46
Total Assets (TTM) in million 35 44 36 79 98
Seq. Total Assets Change -19.7 % 24.07 % -54.76 % -19.52 % -17.7 %
Seq. Net Income Change - -81.16 % -10.51 % 0.89 % 13 %



Return On Assets Company Ranking
Within: No.
Industry # 21
Sector # 52
Overall # 403

Return On Assets Statistics
High Average Low
117.77 %
30.13 %
-62.11 %
(Sep 30 2023)   (Dec 31 2016)





Financial Statements
Molecular Templates Inc 's Assets $ 35 million MTEM's Balance sheet
Molecular Templates Inc 's Income $ -45 million Quarterly MTEM's Income Statement
MTEM's Income by Division See MTEM's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
Y / Y Total Assets Change -63.73 % -49.29 % 37.82 % -19.88 % 24.29 %
Total Assets in million 35 98 192 140 174
Y / Y Net Income Change -91.24 % 11.7 % -20.88 % 51.13 % 129.21 %
Net Income in million 8 93 83 105 69
Return On Assets 22.96 % 95.05 % 43.15 % 75.17 % 39.85 %




Comment on MTEM's ROA in the fiscal year ending 2023
In the fiscal year 2023 Molecular Templates Inc 's ROA decreased compared to previous year to 22.96 %, due to deterioration of net income -91.24 % to $8.12 million, from $92.72 million a year ago, as MTEM's assets were $35.38 million.


More Return On Assets Ratios
MTEM's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MTEM's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for MTEM's Competitors
Roa for Molecular Templates Inc 's Suppliers
Return On Assets for MTEM's Customers

You may also want to know
MTEM's Roi MTEM's Inventory Turnover Ratio MTEM's Growth Rates MTEM's Dividend Comparisons
MTEM's Profitability Ratios MTEM's Asset Turnover Ratio MTEM's Dividend Growth
MTEM's Roe MTEM's Valuation Ratios MTEM's Financial Strength Ratios MTEM's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector ROA
Enzo Biochem Inc  32.62 %
Mimedx Group Inc   30.15 %
Aeon Biopharma inc   28.44 %
Idexx Laboratories Inc  28.11 %
Elite Pharmaceuticals Inc   27.42 %
Semler Scientific Inc   27.15 %
Alpha Tau Medical Ltd   27.15 %
Virios Therapeutics Inc   25.72 %
National Research Corporation  24.27 %
Mettler toledo International Inc   23.50 %
Inmode Ltd   22.93 %
Lantheus Holdings Inc   22.30 %
Johnson and Johnson  19.49 %
Medpace Holdings Inc   19.02 %
Earth Science Tech Inc   18.41 %
Corcept Therapeutics Inc  17.90 %
Chemed Corporation  17.68 %
Cardiff Lexington Corporation  17.40 %
Vertex Pharmaceuticals Inc  17.28 %
Harmony Biosciences Holdings inc   16.82 %
Motus Gi Holdings Inc   16.77 %
Zoetis Inc   16.75 %
Catalyst Pharmaceuticals Inc   16.47 %
West Pharmaceutical Services Inc   15.85 %
Halozyme Therapeutics Inc   15.78 %
Edwards Lifesciences Corporation  15.38 %
Exelixis Inc   15.25 %
Ladrx Corporation  15.13 %
Novartis Ag  14.86 %
Alpha Pro Tech Ltd   14.69 %


Date modified: 2024-04-03T11:07:11+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com